NAYA BIOSCIENCES INC. - COMMON STOCK

0,4999

13-января-25 10:49:34

15 мин. задержка

Акции

-0,3135

-38,54%

Сегодняшний диапазон

0,4900 - 0,7000

ISIN

N/A

Источник

NASDAQ

NAYA Biosciences Announces Pricing of $9.5 Million Public Offering

13 янв 2025 08:15:44 Источник Nasdaq GlobeNewswire
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody

06 янв 2025 07:30:00 Источник Nasdaq GlobeNewswire
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

31 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma

24 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences

21 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)

14 окт 2024 08:18:20 Источник Nasdaq GlobeNewswire
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA

14 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
INVO Reports Record First Quarter 2024 Financial Results

15 май 2024 15:15:00 Источник Nasdaq GlobeNewswire
INVO Reports Fourth Quarter and Full Year 2023 Financial Results

16 апр 2024 15:59:29 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.